跳至主要内容
临床试验/JPRN-jRCTs041210166
JPRN-jRCTs041210166进行中(未招募)4 期

Study on the pathological reduction effect of dementia patients by taking probiotics-Placebo-controlled, exploratory, double-blind study- - Japan Intervention of Cognition Improving Bifidobacteria: JICIB

Akatsu Hiroyasu0 个研究点目标入组 70 人开始时间: 2022年3月22日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 50age old 至 ot applicable(—)
性别
All

入选标准

  • (1) MMSE-J (Nippon Bunka Kagakusha) score is 10-26
  • (2) Persons who have entered a facility related to Fukushimura Hospital and are attending Fukushimura Hospital if they are 50 years of age or older at the time of obtaining consent.
  • (3) Persons who have been receiving medical treatment in the same environment for one month or more and are expected to receive medical treatment in the same environment in the future.
  • (4) A person who has a substitute (guarantor at the time of admission / admission) when it is difficult to obtain document consent from the person

排除标准

  • (1) Those who have difficulty ingesting orally
  • (2) Persons with impaired consciousness
  • (3) Those who have difficulty going to Fukushimura Hospital
  • (4) Persons with hearing impairment that can affect psychological tests
  • (5) Persons with MMSE-J (Nippon Bunka Kagakusha) score of 9 points or less or 27 points or more
  • (6) When there are obvious lesions other than neurodegenerative diseases in the brain such as cerebrovascular accident, normal pressure hydrocephalus, subdural hematoma, and brain tumor by prior imaging examination
  • (7) Persons with physical complications that may affect the study
  • (8) Others who are judged to be inappropriate by the investigator

研究者

发起方
Akatsu Hiroyasu

相似试验

Cognitive improvement bifidobacteria intervention... | 临床试验